Atopic dermatitis: a candidate for disease-modifying strategy (Q26828477)

Omics technologies, data and bioinformatics principles

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

From atopic dermatitis to asthma: the atopic march

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Advances in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Linking allergy to autoimmune disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

The natural course of atopic dermatitis from birth to age 7 years and the association with asthma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Cytokine modulation of atopic dermatitis filaggrin skin expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Topical tacrolimus in the treatment of atopic dermatitis--does it benefit the airways? A 4-year open follow-up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Recall antigen reactions in patients with atopic dermatitis treated with tacrolimus ointment for 1 year

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Do boys do the atopic march while girls dawdle?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Filaggrin mutations, atopic eczema, hay fever, and asthma in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

An update on the genetics of atopic dermatitis: scratching the surface in 2009.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Childhood eczema and rhinitis predict atopic but not nonatopic adult asthma: A prospective cohort study over 4 decades

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Does "autoreactivity" play a role in atopic dermatitis?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

The emerging roles of serine protease cascades in the epidermis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Langerhans cell phenotyping: a new tool for differential diagnosis of inflammatory skin diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Molecular pathogenesis and clinical implications of eczema herpeticum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Development of allergies and asthma in infants and young children with atopic dermatitis--a prospective follow-up to 7 years of age.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Loss-of-Function Mutations in the Filaggrin Gene Lead to Reduced Level of Natural Moisturizing Factor in the Stratum Corneum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

1 reference

7 January 2021

Filaggrin mutations associated with skin and allergic diseases.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Does eczema lead to asthma?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Autoimmunity and atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Atopic march: link to upper airways.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Biomarkers of Th2 polarity are predictive of staphylococcal colonization in subjects with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Protease-antiprotease imbalance may be linked to potential defects in profilaggrin proteolysis in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Levels of soluble ICAM-1 in atopic dermatitis. A new marker for monitoring the clinical activity?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Atopic dermatitis - from new pathophysiologic insights to individualized therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Increased serum thymic stromal lymphopoietin in children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Prediction of atopic dermatitis in 2-yr-old children by cord blood IgE, genetic polymorphisms in cytokine genes, and maternal mentality during pregnancy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Serum measurement of interleukin-31 (IL-31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

A 10 year asthma programme in Finland: major change for the better

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Biomarkers for itch and disease severity in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

The endophenotype concept in psychiatry: etymology and strategic intentions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Systems medicine and integrated care to combat chronic noncommunicable diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Atopic dermatitis and asthma: parallels in the evolution of treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Asthma symptoms in pediatric patients: differences throughout the seasons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

A 10-year open follow-up of eczema and respiratory symptoms in patients with atopic dermatitis treated with topical tacrolimus for the first 4 years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

Eotaxin-3/CC chemokine ligand 26 is a functional ligand for CX3CR1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2012.02845.X

7 January 2021

10.1111/J.1398-9995.2012.02845.X

Identifiers

DOI

0 references

Fatcat ID

release_ibuf4ejo7nazbpja6a6bboxdpm

0 references

PubMed publication ID

22671706

1 reference